CRISPR/Cas9 revitalizes adoptive T-cell therapy for cancer immunotherapy

Cancer immunotherapy has gained attention as the supreme therapeutic modality for the treatment of various malignancies. Adoptive T-cell therapy (ACT) is one of the most distinctive modalities of this therapeutic approach, which seeks to harness the potential of combating cancer cells by using autol...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghaffari, Sasan, Khalili, Nastaran, Rezaei, Nima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390258/
https://www.ncbi.nlm.nih.gov/pubmed/34446084
http://dx.doi.org/10.1186/s13046-021-02076-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390258/
https://www.ncbi.nlm.nih.gov/pubmed/34446084
http://dx.doi.org/10.1186/s13046-021-02076-5

Ejemplares similares